Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: A Randomized controlled trial

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 6, 2011, Pages 1337-1344

  Takatori, Yuji ^a   Akagi, Shigeru ^b   Sugiyama, Hitoshi ^b   Inoue, Junko ^b   Kojo, Shoichiro ^a   Morinaga, Hiroshi ^a   Nakao, Kazushi ^a   Wada, Jun ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; EXTRANEAL; GLUCOSE; HEMOGLOBIN A1C; ICODEXTRIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG EFFICACY; FEMALE; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIPID METABOLISM; MALE; MULTICENTER STUDY; OPEN STUDY; PERITONEAL DIALYSIS; PERITONEUM; PERITONEUM FUNCTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME; URINE VOLUME;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; CREATININE; DIABETIC NEPHROPATHIES; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME; WATER-ELECTROLYTE BALANCE;

EID: 79958205955     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10041110     Document Type: Article

References (26)

1. Kuriyama S: Peritoneal dialysis in patients with diabetes: Are the benefits greater than the disadvantages? Perit Dial Int 27[Suppl 2]: S190-S195, 2007
2. Masakane I, Tsubakihara Y, Akiba T, Watanabe Y, Iseki K: The most recent trends of peritoneal dialysis in Japan. Perit Dial Int 28[Suppl 3]: S27-S31, 2008
3. Mistry CD, Gokal R, Peers E: A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenternvestigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 46: 496-503, 1994
4. Mistry CD, Mallick NP, Gokal R: Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges. Lancet 2: 178-182, 1987
5. Frampton JE, Plosker GL: Icodextrin: A review of its use in peritoneal dialysis. Drugs 63: 2079-2105, 2003
6. Wolfson M, Piraino B, Hamburger RJ, Morton AR: A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 40: 1055-1065, 2002
7. Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM: Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant 15: 862-866, 2000
8. Van V, Schoonjans RS, Struijk DG, Verbanck JJ, Vanholder RC, Van B, Lefebvre RA, De V, Lameire NH: Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Perit Dial Int 22: 32-38, 2002
9. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann HP, Heimburger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC: Icodextrin improves the fluid status of peritoneal dialysis patients: Results of a double-blind randomized controlled trial. J Am Soc Nephrol 14: 2338-2344, 2003
10. Jeloka TK, Oreopoulos DG: Is ultrafiltration with icodextrin higher in diabetics than in nondiabetics? Perit Dial Int 26: 729-730, 2006
11. Adachi Y, Nakagawa Y, Nishio A: Icodextrin preserves residual renal function in patients treated with automated peritoneal dialysis. Perit Dial Int 26: 405-407, 2006
12. Twardowski ZJ: Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 7: 95-108, 1989
13. Paniagua R, Ventura MD, Avila-Diaz M, Cisneros A, Vicente- Martinez M, Furlong MD, Garcia-Gonzalez Z, Villanueva D, Orihuela O, Prado-Uribe MD, Alcantara G, Amato D: Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int 29: 422-432, 2009
14. Paniagua R, Orihuela O, Ventura MD, Avila-Diaz M, Cisneros A, Vicente-Martinez M, Furlong MD, Garcia-Gonzalez Z, Villanueva D, Prado-Uribe MD, Alcantara G, Amato, D: Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis. Kidney Int Suppl: S125-S130, 2008
15. Babazono T, Nakamoto H, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, Hamada C, Furuya R, Hasegawa H, Kasahara M, Moriishi M, Tomo T, Miyazaki M, Sato M, Yorioka N, Kawaguchi Y: Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol 27: 409-415, 2007
16. Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW: Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 64: 1480-1486, 2003
17. Martikainen T, Teppo AM, Gronhagen-Riska C, Ekstrand A: Benefit of glucose-free dialysis solutions on glucose and lipid metabolism in peritoneal dialysis patients. Blood Purif 23: 303-310, 2005
18. Cho KH, Do JY, Park JW, Yoon KW: Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients. Nephrol Dial Transplant 25: 593-599, 2010
19. Nakao A, Nakao K, Takatori Y, Kojo S, Inoue J, Akagi S, Sugiyama H, Wada J, Makino H: Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZinduced diabetic rat model with partial nephrectomy. Nephrol Dial Transplant 25: 1479-1488, 2010
20. Parikova A, Zweers MM, Struijk DG, Krediet RT: Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial 19: 186-190, 2003
21. Martikainen T, Ekstrand A, Honkanen E, Teppo AM, Gronhagen- Riska C: Do interleukin-6, hyaluronan, soluble intercellular adhesion molecule-1 and cancer antigen 125 in dialysate predict changes in peritoneal function? A 1-year follow-up study. Scand J Urol Nephrol 39: 410- 416, 2005
22. Moriishi M, Kawanishi H: Icodextrin and intraperitoneal inflammation. Perit Dial Int 28[Suppl 3]: S96 -S100, 2008
23. Martikainen TA, Teppo AM, Gronhagen-Riska C, Ekstrand AV: Glucose-free dialysis solutions: Inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int 25: 453-460, 2005
24. Trigka K, Dousdampanis P, Chu M, Khan S, Ahmad M, Bargman JM, Oreopoulos, DG: Encapsulating peritoneal sclerosis: A single-center experience and review of the literature. Int Urol Nephrol 2010
25. Krediet RT: Effects of icodextrin on the peritoneal membrane. Nephrol Dial Transplant 25: 1373-1375, 2010
26. Kawanishi H, Shintaku S, Shishida M, Morrishi M, Tsuchiya S, Dohi K: A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritoneal solution. Adv Perit Dial 25: 45-49, 2009